🔗 Share this article

Treasury head Reeves has stated she is preparing "targeted action to address cost of living issues" in the forthcoming financial statement.

Speaking to the BBC, she noted that reducing price rises is a collective task of both the administration and the Bank of England.

The United Kingdom's price growth is expected to be the highest among the Group of Seven advanced economies this calendar year and the following year.

Potential Utility Bill Measures

It is understood the government could take action to bring down utility costs, such as by slashing the current 5% level of VAT applied on energy supplies.

Another option is to reduce some of the government charges presently included in household expenses.

Budgetary Constraints and Analyst Predictions

The administration will obtain the latest assessment from the official forecaster, the Office for Budget Responsibility, on Monday, which will reveal how much scope there is for such measures.

The consensus from most analysts is that the Chancellor will have to introduce tax increases or budget cuts in order to fulfill her self-imposed debt limits.

Earlier on Thursday, analysis suggested there was a twenty-two billion pound shortfall for the chancellor to address, which is at the more modest range of forecasts.

"It is a shared job between the Bank of England and the administration to bear down further on some of the sources of inflation," the Chancellor told reporters in the US capital, at the annual meetings of the International Monetary Fund and global financial institution.

Revenue Pledges and International Concerns

While much of the focus has been on probable tax increases, the chancellor said the most recent figures from the fiscal watchdog had not altered her commitment to campaign commitments not to raise tax levels on income tax, sales tax or social security contributions.

She attributed an "uncertain world" with growing geopolitical and trade tensions for the Budget revenue measures, likely to be targeted on those "with the broadest shoulders."

International Economic Disputes

Referring to apprehensions about the UK's economic relations with the Asian nation she said: "The UK's national security invariably take priority."

Recent statement by Chinese authorities to strengthen trade restrictions on rare earths and other materials that are crucial for advanced tech manufacturing led American leader Donald Trump to threaten an additional 100% import tax on goods from the Asian country, raising the possibility of an full-scale commercial conflict between the two global powers.

The American finance chief called the Chinese move "commercial pressure" and "a global supply chain power grab."

Inquired about considering the US offer to participate in its conflict with China, the Chancellor said she was "deeply worried" by Chinese actions and urged the Beijing authorities "to avoid restrictions and limit trade."

She said the move was "harmful for the international commerce and causes additional challenges."

"In my view there are sectors where we must challenge Chinese policies, but there are also valuable prospects to trade with Chinese markets, including financial services and other sectors of the economic system. We've got to achieve that balance right."

The Treasury chief also stated she was collaborating with other major economies "on our own critical minerals strategy, so that we are more independent."

NHS Medicine Costs and Funding

Reeves also acknowledged that the cost the NHS spends on drugs could go up as a result of ongoing talks with the Trump administration and its drugs companies, in exchange for lower tariffs and investment.

Some of the biggest global drug companies have said lately that they are either pausing or canceling projects in the United Kingdom, with several attributing the modest returns they are receiving.

Last month, the government science advisor said the cost the NHS pays for drugs would must increase to stop firms and pharmaceutical investment leaving the UK.

The Chancellor informed the BBC: "It has been observed as a result of the cost structure, that clinical trials, recent pharmaceuticals have not been offered in the United Kingdom in the way that they are in other continental states."

"We want to guarantee that individuals getting care from the NHS are can receive the top critical drugs in the world. And so we are reviewing this situation, and... looking to secure additional investment into Britain."